Thao Vu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Thao Vu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Annette Jane Dobson
School of Public Health, Faculty of Medicine, University of Queensland, Brisbane, Australia
1 shared publication - Joanne Ryan
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
1 shared publication - Leon Flicker
Western Australian Centre for Health and Ageing, The University of Western Australia, Perth, Western Australia, Australia
1 shared publication - Michael Waller
School of Public Health, The University of Queensland, Brisbane, Australia
1 shared publication - Michelle Wilson
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
1 shared publication - Osvaldo P. Almeida
Institute for Health Research University of Notre Dame Fremantle Western Australia Australia
1 shared publication
Latest Publications
- 1 September 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 107 (2) , 671-681
Validation of multiple linked administrative datasets to identify people with dementia
Background: Accurately measuring dementia prevalence and incidence (including Alzheimer's disease) is important for service planning and chronic condition management. Linked administrative data present an accessible and inexpensive method to estimate dementia prevalence and incidence. Objective: To examine the accuracy of identifying people with dementia in linked administrative data through comparison with adjudicated cases of dementia from a community-based clinical trial. Methods: We created a comprehensive linked administrative dataset containing people with dementia in Australia and used it to develop algorithms that identified people with dementia. These algorithms were tested against adjudicated cases of dementia (both confirmed and not confirmed) in the ASPirin in Reducing Events in the Elderly (ASPREE) clinical trial (Number: ISRCTN83772183, Registration date: 14/07/2005) to help determine optimal sensitivity and specificity. Results: The algorithm that provided the highest sensitivity and positive predictive value estimates on balance without excluding ASPREE trial participants with suspected (but not confirmed) dementia was having at least one record for dementia in a minimum of two sources or two records with dementia in one source based on truncating the timeframe of randomization in the ASPREE trial to one year from the date that the first participant was randomized. This algorithm produced a sensitivity of 70.7%, specificity of 98.2%, positive predictive value of 72.6% and negative predictive value of 98.1%. Conclusions: Linked administrative data can identify people with dementia with moderate accuracy. This is promising but requires enhancement before it can be used for estimating dementia prevalence and incidence. Clinical trial name and URL: ASPirin in Reducing Events in the Elderly; ISRCTN - ISRCTN83772183: ASPirin in Reducing Events in the Elderly ( https://www.isrctn.com/ISRCTN83772183 )
- 1 September 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 107 (2) , 671-681
Validation of multiple linked administrative datasets to identify people with dementia
Background: Accurately measuring dementia prevalence and incidence (including Alzheimer's disease) is important for service planning and chronic condition management. Linked administrative data present an accessible and inexpensive method to estimate dementia prevalence and incidence. Objective: To examine the accuracy of identifying people with dementia in linked administrative data through comparison with adjudicated cases of dementia from a community-based clinical trial. Methods: We created a comprehensive linked administrative dataset containing people with dementia in Australia and used it to develop algorithms that identified people with dementia. These algorithms were tested against adjudicated cases of dementia (both confirmed and not confirmed) in the ASPirin in Reducing Events in the Elderly (ASPREE) clinical trial (Number: ISRCTN83772183, Registration date: 14/07/2005) to help determine optimal sensitivity and specificity. Results: The algorithm that provided the highest sensitivity and positive predictive value estimates on balance without excluding ASPREE trial participants with suspected (but not confirmed) dementia was having at least one record for dementia in a minimum of two sources or two records with dementia in one source based on truncating the timeframe of randomization in the ASPREE trial to one year from the date that the first participant was randomized. This algorithm produced a sensitivity of 70.7%, specificity of 98.2%, positive predictive value of 72.6% and negative predictive value of 98.1%. Conclusions: Linked administrative data can identify people with dementia with moderate accuracy. This is promising but requires enhancement before it can be used for estimating dementia prevalence and incidence. Clinical trial name and URL: ASPirin in Reducing Events in the Elderly; ISRCTN - ISRCTN83772183: ASPirin in Reducing Events in the Elderly ( https://www.isrctn.com/ISRCTN83772183 )